Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (U01CA214369)
U.S. Department of Health & Human Services | U.S. Food and Drug Administration (RFA-FD-18-023)
Gouvernement du Canada | Canadian Institutes of Health Research (DFS-152267)
Article History
Received: 19 June 2019
Accepted: 30 September 2019
First Online: 13 January 2020
Change Date: 24 January 2020
Change Type: Update
Change Details: Fig. 1 as initially published had labels that were too small to be legible. The figure was replaced, and the legend text adapted accordingly, on 24 January 2020.
Competing interests
: An international patent application (WO2018013797A1) describes APC-ms compositions. A.S.C. is a co-founder of Immulus, Inc. D.J.M. is a co-founder, advisor, and chair of Immulus’ scientific advisory board. D.K.Y.Z. declares no competing interests.